Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study

Restuccia, T; Ortega, R; Guevara, M; Gines, P; Alessandria, C; Ozdogan, OSMAN; Navasa, M; Rimola, A; Garcia-Valdecasas, JC; Arroyo, V; Rodes, J

doi:10.1016/j.jhep.2003.09.019

Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study

Atıf İçin Kopyala

Restuccia T., Ortega R., Guevara M., Gines P., Alessandria C., Ozdogan O. C., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.40, sa.1, ss.140-146, 2004 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 40 Sayı: 1
Basım Tarihi: 2004
Doi Numarası: 10.1016/j.jhep.2003.09.019
Dergi Adı: JOURNAL OF HEPATOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.140-146
Anahtar Kelimeler: hepatorenal syndrome, liver transplantation, posttransplantation, PRETRANSPLANT RENAL-FUNCTION, LIVER-TRANSPLANTATION, PROGNOSTIC VALUE, SURVIVAL, CIRRHOSIS, ALBUMIN, THERAPY, TERLIPRESSIN, TYPE-1, MODEL
Marmara Üniversitesi Adresli: Evet

Özet

Background: Pretransplant renal function is the major determinant of survival after liver transplantation (LTx). Patients with hepatorenal syndrome (HRS) have a poor outcome after LTx compared with patients transplanted without HRS.